MMV367 1500mg: Clinical Trials

1 trial of MMV367 1500mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow MMV367 1500mg: new trials by email Literature Review of MMV367 1500mg trials Research Report on MMV367 1500mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum
MMV367 3mg, P. falciparum IBSM infection, MMV367 5mg - Infections, Vector Borne Diseases
Phase 1CompletedMedicines for Malaria Venture122023-08-012025-12-10

Conditions studied

Infections (1)  ·  Inflammation (1)  ·  Malaria (1)  ·  Malaria, Falciparum (1)  ·  Parasitemia (1)  ·  Parasitic Diseases (1)  ·  Pathologic Processes (1)  ·  Protozoan Infections (1)  ·  Systemic Inflammatory Response Syndrome (1)  ·  Vector Borne Diseases (1)

Sponsors

Medicines for Malaria Venture (1)

Countries

Australia (1)

Top investigators

Benoit Bestgen, PhD (1)